June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Disease activity of geographic atrophy in fellow eyes of the pegcetacoplan phase III studies measured by automated AI-based OCT biomarker quantifications
Author Affiliations & Notes
  • Gregor Sebastian Reiter
    Medizinische Universitat Wien, Wien, Wien, Austria
  • Julia Mai
    Medizinische Universitat Wien, Wien, Wien, Austria
  • Sophie Frank
    Medizinische Universitat Wien, Wien, Wien, Austria
  • Oliver Leingang
    Medizinische Universitat Wien, Wien, Wien, Austria
  • Wolf-Dieter Vogl
    RetInSight GmbH, Austria
  • Amir Sadeghipour
    RetInSight GmbH, Austria
  • Hrvoje Bogunovic
    Medizinische Universitat Wien, Wien, Wien, Austria
  • Ursula Schmidt-Erfurth
    Medizinische Universitat Wien, Wien, Wien, Austria
  • Footnotes
    Commercial Relationships   Gregor Reiter RetInSight GmbH, Code F (Financial Support); Julia Mai None; Sophie Frank None; Oliver Leingang None; Wolf-Dieter Vogl RetInSight GmbH, Code E (Employment); Amir Sadeghipour RetInSight GmbH, Code E (Employment); Hrvoje Bogunovic Heidelberg Engineering, Apellis, RetInSight, Code F (Financial Support), Bayer, Apellis, Code R (Recipient); Ursula Schmidt-Erfurth Apellis, Code C (Consultant/Contractor), Genentech, Kodiak, Novartis, Apellis, RetInSight, Code F (Financial Support), RetInSight, Code P (Patent)
  • Footnotes
    Support  Research Grant Apellis, Christian Doppler Society Grant
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 317. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gregor Sebastian Reiter, Julia Mai, Sophie Frank, Oliver Leingang, Wolf-Dieter Vogl, Amir Sadeghipour, Hrvoje Bogunovic, Ursula Schmidt-Erfurth; Disease activity of geographic atrophy in fellow eyes of the pegcetacoplan phase III studies measured by automated AI-based OCT biomarker quantifications. Invest. Ophthalmol. Vis. Sci. 2023;64(8):317.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To measure disease progression of geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in untreated fellow eyes in bilateral GA patients from two large phase III clinical studies using automated AI-based quantifications of the outer retina on optical coherence tomography (OCT).

Methods : Fellow eyes presenting with GA from two phase III randomized controlled studies (OAKS, NCT03525613 and DERBY, NCT03525600) were analyzed. Eyes showing signs of macular neovascularization were excluded from the analysis. Photoreceptor (PR) and retinal pigment epithelium (RPE) loss were quantified on Spectralis OCT using fully automated AI-based algorithms. Longitudinal PR/RPE loss ratios were calculated and investigated over time. To reduce the influence of baseline lesion size, PR and RPE loss growth rates were calculated for each study year after performing a square root transformation and were assessed in mm/year.

Results : 753 fellow eyes from OAKS and DERBY combined were included. 369 eyes presented with and 384 eyes without subfoveal atrophy, respectively. At baseline, mean (SD) area of PR loss was similar between eyes with and without subfoveal GA with 11.25 (6.29) vs. 11.23 (5.85) mm2, respectively. Furthermore, no significant increase of PR loss could be observed between the two groups (p=0.079). Eyes without subfoveal GA at baseline had a significantly smaller mean RPE loss area (6.91 (4.6) vs 8.63 (4.86) mm2). PR/RPE loss ratios were consistently and significantly larger in patients without subfoveal GA for the complete study period of 24 months (p<0.001). Nonetheless, a convergence of PR/RPE loss ratios between eyes with and without subfoveal involvement can be observed as the PR/RPE loss ratio was significantly larger during the first study year compared to the second study year (p=0.01). This can be explained by a significantly faster progression (p<0.001) of RPE loss during the first (0.343 (0.328) vs 0.275 (0.188) mm/year (SD)) and second year (0.354 (0.276) vs. 0.257 (0.177) mm/year (SD)) in patients without subfoveal GA.

Conclusions : Automated quantification of the outer retina layers with advanced OCT-based AI tools enables personalized patient monitoring of disease activity over time. PR/RPE loss ratios decrease in patients without subfoveal GA, suggesting decelerating RPE degeneration over time in this subgroup.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×